Mapping of the US domestic influenza virologic surveillance landscape

Emerging Infectious Diseases

Volumn 24, Issue 7, 2018, Pages 1300-1306

  Jester, Barbara ^a,e   Schwerzmann, Joy ^a   Mustaquim, Desiree ^b   Aden, Tricia ^b   Brammer, Lynnette ^b   Humes, Rosemary ^c   Shult, Pete ^d   Shahangian, Shahram ^b   Gubareva, Larisa ^b   Xu, Xiyan ^b   Miller, Joseph ^b   Jernigan, Daniel ^b  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Biomedical Advanced Research and Development Authority   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; SIALIDASE;

ARTICLE; DISEASE SURVEILLANCE; HEMAGGLUTINATION; HUMAN; INFLUENZA; INFLUENZA VIRUS; PUBLIC HEALTH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SANGER SEQUENCING; VACCINE PRODUCTION; VIRUS ISOLATION; HEALTH SURVEY; INFLUENZA A VIRUS; INFLUENZA B VIRUS; PREVALENCE; UNITED STATES; VIROLOGY;

HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; POPULATION SURVEILLANCE; PREVALENCE; UNITED STATES;

EID: 85050488079     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2407.180028     Document Type: Article

References (21)

1. Rolfes MA, Foppa IM, Garg S, Flannery B, Brammer L, Singleton JA, et al. Estimated influenza illnesses, medical visits, hospitalizations, and deaths averted by vaccination in the United States. 2017 [updated 2017 Apr 19; cited 2017 Dec 29]. https://www.cdc.gov/flu/about/disease/2015-16.htm
2. Centers for Disease Control and Prevention. Overview of influenza surveillance in the United States. 2017 [updated 2017 Oct 13; cited 2017 Dec 29]. http://www.cdc.gov/flu/weekly/overview.htm
3. Jernigan DB, Lindstrom SL, Johnson JR, Miller JD, Hoelscher M, Humes R, et al. Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. Clin Infect Dis. 2011;52(Suppl 1):S36–43. http://dx.doi.org/10.1093/cid/cijq020
4. Department of Health and Human Services. Pandemic Influenza Plan: 2017 Update. 2017 [updated 2017 Jun 15; cited 2017 Dec 29]. https://www.cdc.gov/flu/pandemic-resources/pdf/pan-flu-report-2017v2.pdf
5. Truven Health Analytics. Marketscan research databases. 2017 [cited 2017 Dec 29]. http://truvenhealth.com/your-healthcare-focus/analytic-research/marketscan-research-databases
6. Millman AJ, Reed C, Kirley PD, Aragon D, Meek J, Farley MM, et al. Improving accuracy of influenza-associated hospitalization rate estimates. Emerg Infect Dis. 2015;21:1595–601. http://dx.doi.org/10.3201/eid2109.141665
7. Reed C, Chaves SS, Daily Kirley P, Emerson R, Aragon D, Hancock EB, et al. Estimating influenza disease burden from population-based surveillance data in the United States. PLoS One. 2015;10:e0118369. http://dx.doi.org/10.1371/journal.pone.0118369
8. Williams LO, Kupka NJ, Schmaltz SP, Barrett S, Uyeki TM, Jernigan DB. Rapid influenza diagnostic test use and antiviral prescriptions in outpatient settings pre-and post-2009 H1N1 pandemic. J Clin Virol. 2014;60:27–33. http://dx.doi.org/10.1016/j.jcv.2014.01.016
9. Centers for Disease Control and Prevention. Guidance for clinicians on the use of RT-PCR and other molecular assays for diagnosis of influenza virus infection. 2017 [updated 2016 Oct 25; cited 2017 Dec 29]. http://www.cdc.gov/flu/professionals/diagnosis/molecular-assays.htm
10. Fowlkes A, Dasgupta S, Chao E, Lemmings J, Goodin K, Harris M, et al. Estimating influenza incidence and rates of influenza-like illness in the outpatient setting. Influenza Other Respi Viruses. 2013;7:694–700. http://dx.doi.org/10.1111/irv.12014
11. Flannery B, Chung JR, Thaker SN, Monto AS, Martin ET, Belongia EA, et al. Interim estimates of 2016–17 seasonal influenza vaccine effectiveness—United States, February 2017. MMWR Morb Mortal Wkly Rep. 2017;66:167–71. http://dx.doi.org/10.15585/mmwr.mm6606a3
12. Association of Public Health Laboratories. CDC-APHL influenza virologic surveillance right size sample size calculators. 2017 [cited 2017 Dec 29]. https://www.aphl.org/programs/infectious_disease/influenza/Influenza-Virologic-Surveillance-Right-Size-Roadmap/Pages/Influenza-Sample-Size-Calculators.aspx
13. GISAID Initiative. 2017 [cited 2017 Dec 29]. https://www.gisaid.org/
14. National Institutes of Health. GenBank overview; 2017 [cited 2017 Dec 29]. https://www.ncbi.nlm.nih.gov/genbank/
15. Centers for Disease Control and Prevention. FluView: weekly U.S. influenza surveillance report; 2017 [updated 2017 Dec 29; cited 2017 Dec 29]. http://www.cdc.gov/flu/weekly/
16. Centers for Disease Control and Prevention. Summary of Influenza Risk Assessment Tool (IRAT) results. 2017 [updated 2017 Oct 23; cited 2017 Dec 29]. https://www.cdc.gov/flu/pandemic-resources/monitoring/irat-virus-summaries.htm
17. Rubin RJ, Gregg MB. Influenza surveillance in the United States 1972–1974. Am J Epidemiol. 1975;102:225–32. http://dx.doi.org/10.1093/oxfordjournals.aje.a112151
18. Hayden RT, Wick MT, Rodriguez AB, Caliendo AM, Mitchell MJ, Ginocchio CC. A survey-based assessment of United States clinical laboratory response to the 2009 H1N1 influenza outbreak. Arch Pathol Lab Med. 2010;134:1671–8.
19. Quiñones-Mateu ME, Avila S, Reyes-Teran G, Martinez MA. Deep sequencing: becoming a critical tool in clinical virology. J Clin Virol. 2014;61:9–19. http://dx.doi.org/10.1016/j.jcv.2014.06.013
20. Rosenthal M, Anderson K, Tengelsen L, Carter K, Hahn C, Ball C. Evaluation of sampling recommendations from the Influenza Virologic Surveillance Right Size Roadmap for Idaho. JMIR Public Health Surveill. 2017;3:e57. http://dx.doi.org/10.2196/publichealth.6648
21. Centers for Disease Control and Prevention. International Reagent Resource (formerly the Influenza Reagent Resource). 2017 [cited 2017 Dec 29]. https://www.internationalreagentresource.org/